Published on 3 May 2024 on GuruFocus.com via Yahoo Finance
Pharmacy revenues surge by nearly 31% in Q1 2024, signaling robust growth in the segment.Adjusted income from operations climbs 16%, reflecting operational efficiency and strategic gains.Shareholders' net loss driven by equity securities impairment, overshadowing operational progress.Strategic divestiture of Medicare Advantage and related businesses poised to reshape future operations.
Warning! GuruFocus has detected 9 Warning Signs with CMI.